PATENT CLAIM ANALYSIS

Application Number: 16186077
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "562000"]

Abstract:
Divalent salts of S-allylmercapto-N-acetylcysteine and related compositions are disclosed which can be administered in order to provide protection from the formation of aldehyde-protein adducts, protein carbonylation, protein aggregation, and the resulting neuroinflammation. Various neurodegenerative diseases which are suitable for treatment using these compositions include Alzheimer's disease, senile dementia, Parkinson's disease, multiple sclerosis, Lewy body disease, peripheral neuropathy, spinal cord injury, stroke and cerebral ischemia.

Claim (Index 25):
The method of claim  1  where said organosulfur composition is a drug.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.36842
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15387181', '13694447', '13373878', '15530804', '10853415']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8265249996762977
- 35 USC 102 Novelty (BERT): 0.6340427389015219
- Combined Prediction Score: 0.80727677359882
- Mean Citation Score: 490.64977000000016
- Max Citation Score: 592.0988
- Similarity Product: 559.504598916483

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test